【レポートの概要（一部）】
1. Report Overview
1.1 Global Pain Management Devices Market Overview
1.2 Global Pain Management Devices Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. An Introduction to Pain and Pain Management
2.1 Pain: A Sensory And Emotional Phenomenon
2.1.1 Pain: A Short History
2.1.2 Pain Pathways And The Origin Of Pain
2.2 The World Health Organisation (WHO) Pain Ladder
2.2.1 Classification Of Pain
2.2.1.1 Acute Pain
2.2.1.2 Chronic Pain
2.3 The Psychosocial Effects Of Chronic Pain
2.3.1 Chronic Cancer Pain
2.3.2 Neuropathic Pain
2.3.3 Identifying Neuropathic Pain
2.4 The Neurochemistry Of Pain
2.4.1 Prostaglandins
2.4.2 Opioids
2.5 Pain Management – A Brief Overview
2.6 Pain Management Drugs
2.6.1 The Use Of Opioids In Pain Management
2.6.2 OTC Pain Relievers
2.7 Pain Management Devices
2.7.1 Radiofrequency Ablation Devices
2.7.2 Analgesic Pumps
2.7.2.1 Types Of Infusion
2.7.2.2 Advantages And Disadvantages Of Infusion Pumps
2.7.3 Intradiscal Electrothermal Therapy
2.7.4 Neurostimulation
2.7.4.1 Spinal Cord Stimulation
2.7.4.2 Deep Brain Stimulation
2.7.4.3 Occipital Nerve Stimulation
2.7.5 Microcurrent Electrical Neuromuscular Stimulation
2.7.6 Transcutaneous Electrical Nerve Stimulation
2.8 Medical Devices Classification Systems
2.8.1 The US Medical Devices Classification System
2.8.2 The EU Medical Devices Classification System
2.9 Regulation Of Medical Devices
2.9.1 The US Approval And Regulation System
2.9.2 The EU Approval And Regulation System
2.9.2.1 Post-Marketing Surveillance In The EU
2.10 Market Definition
3. The Global Pain Management Devices Market: By Device Type, 2014-2024
3.1 The Global Pain Management Market In 2013
3.2 Pain Management Devices: Global Market Overview
3.2.1 The Global Pain Management Devices Market In 2013
3.2.2 Global Pain Management Devices: Market Forecast 2014-2024
3.2.3 Changing Market Shares By Sector 2014-2024
3.3 Analgesia Infusion Pumps Market 2014-2024
3.3.1 Intrathecal Drug Delivery Systems
3.3.2 Patient Controlled Analgesia
3.3.2.1 Costs And Benefits Of PCA Pumps
3.3.2.2 PCA Pumps: Leading Products, 2014
3.3.3 Analgesia Infusion Pumps: Market Forecast 2014-2024
3.4 Spinal Cord Stimulation Market 2014-2024
3.4.1 Spinal Cord Stimulation: Leading Products, 2014
3.4.2 Spinal Cord Stimulation For Pain Management: Market Forecast 2014-2024
3.5 Radiofrequency Ablation Market 2014-2024
3.5.1 Radiofrequency Ablation for Pain Management: Leading Products, 2014
3.5.2 Radiofrequency Ablation for Pain Management: Market Forecast 2014-2024
3.6 Intradiscal Electrothermal Therapy 2014-2024
3.6.1 Intradiscal Electrothermal Therapy for Pain Management: Market Forecast 2014-2024
3.7 Transcutaneous Electrical Nerve Stimulation 2014-2024
3.7.1 Transcutaneous Electrical Nerve Stimulation: Leading Products, 2014
3.7.2 Transcutaneous Electrical Nerve Stimulation For Pain Management: Market Forecast 2014-2024
3.8 Microcurrent Electrical Neuromuscular Stimulation 2014-2024
3.8.1 Microcurrent Electrical Neuromuscular Stimulation For Pain Management: Market Forecast 2014-2024
3.9 Other Pain Management Devices 2014-2024
3.9.1 Occipital Nerve Stimulation As A Pain Management Therapy
3.9.2 Deep Brain Stimulation As A Pain Management Therapy
3.9.3 Other Pain Management Devices: Market Forecast 2014-2024
4. The Global Pain Management Devices Market: By Application, 2014-2024
4.1 Chronic Pain: Variable Causes And Related Conditions
4.2 Pain Management Devices: Applications and Uses
4.2.1 Pain Management Devices Market By Application In 2013
4.2.2 Global Pain Management Devices By Application: Market Forecast 2014-2024
4.2.3 Changing Market Shares By Application 2014-2024
4.3 Musculoskeletal Pain Management Devices Market 2014-2024
4.3.1 Musculoskeletal Pain Management Devices: Leading Products, 2014
4.3.2 Musculoskeletal Pain Management Devices: Market Forecast 2014-2024
4.4 Cancer Pain Management Devices Market 2014-2024
4.4.1 Cancer Pain Management Devices: Leading Products, 2014
4.4.2 Cancer Pain Management Devices: Market Forecast 2014-2024
4.5 Migraine and Facial Pain Management Devices Market 2014-2024
4.5.1 Migraine Relieving Techniques
4.5.2 Migraine Pain Management Devices: Leading Products, 2014
4.5.3 Migraine And Facial Pain Management Devices: Market Forecast 2014-2024
4.6 Neuropathic Pain Management Devices Market 2014-2024
4.6.1 Neuropathic Pain Management Devices: Leading Products, 2014
4.6.2 Neuropathic Pain Management Devices: Market Forecast 2014-2024
4.7 Surgical And Trauma Pain Management Devices Market 2014-2024
4.7.1 Surgical And Trauma Pain Management Devices: Leading Products, 2014
4.7.2 Surgical And Trauma Pain Management Devices: Market Forecast 2014-2024
4.8 The Market For Other Pain Management Devices 2014-2024
4.8.1 The Market For Other Pain Management Devices: Market Forecast 2014-2024
5. Leading National Pain Management Devices Markets 2014-2024
5.1 The Pain Management Devices Market By Region
5.1.1 The Global Distribution Of Pain Management Devices In 2013
5.2 Leading National Markets: Forecast, 2014-2024
5.2.1 Changing Market Shares By Region, 2014-2024
5.3 Regional Pain Management Devices Markets: Analysis and Forecasts, 2014-2024
5.4 United States: The Largest Pain Management Devices Market
5.5 The EU5 Markets
5.5.1 EU5 Markets: Changing Market Shares by Country, 2014-2024
5.5.2 Germany: Fiscal Austerity Programs And Spending Cuts Impacting Market Growth
5.5.3 France: Price Reductions And Lowering Consumption Are Concerns For Market Growth
5.5.4 UK: Private Patient Income Will Help To Offset Low Funding Levels
5.5.5 Italy: Restrictions On The Use Of Analgesic Drugs To Help Boost Pain Devices
5.5.6 Spain: Rationalisation Of Health And Pharmaceutical Expenditure Limiting Market Growth
5.6 China: Shifting Technological Landscape Will Drive Market Growth
5.7 Japan: An Ageing Population Coupled With The Fear Of Opioid Addiction Will Stimulate Pain Devices Uptake
5.8 India: Rising Pain Incidence And Improving Socio-Economic Conditions
5.9 South Korea: Universal Healthcare Coverage And Government Investment Fuelling Market Growth
5.10 Russia: Improving Market Penetration For Pain Devices
5.11 Brazil: Inadequate Infrastructure Limiting Expansion
5.12 Mexico: Heavy Regulation Of Opioid Use To Strengthen Device Uptake
5.13 Rest Of The World
6. Leading Companies in the Pain Management Devices Market, 2014
6.1 Pain Management Devices – A Diversified Market
6.2 BioDelivery Sciences International (BDSI)
6.2.1 BDSI – The BEMA Technology Platform
6.2.2 BDSI: Historical Revenue Analysis, 2009-2013
6.3 Boston Scientific
6.3.1 Boston Scientific: Revenue Analysis, 2013
6.3.2 Boston Scientific – Precision And Precision Spectra Spinal Cord Stimulation Systems
6.3.3 GUIDE DBS And Enspire DBS Systems – Intelect Medical/Boston Scientific
6.4 Cephalon (Teva Pharmaceuticals)
6.4.1 Cephalon’s Pain Management Products
6.4.1.1 Actiq – Cephalon’s Therapy For Cancer Pain
6.5 DJO Global (Empi Inc)
6.5.1 Empi Inc
6.5.2 Empi’s Electrotherapy Products
6.5.3 Empi’s Iontophoresis Patch Systems
6.6 Endo Pharmaceuticals
6.6.1 Endo Pharmaceuticals: Historical Revenue Analysis, 2011-2013
6.6.2 Endo Pharmaceuticals Pain Management – Lidoderm
6.7 Hospira
6.7.1 Hospira: Historical Revenue Analysis, 2009-2013
6.7.2 Hospira – LifeCare PCA Infusion System
6.8 Kimberly-Clark Health Care
6.8.1 Kimberly-Clark: Revenue Analysis
6.8.2 Kimberly-Clark’s Cooled Radiofrequency System for Chronic Pain Relief
6.9 Medtronic
6.9.1 Medtronic: Historical Revenue Analysis, 2013-2014
6.9.2 Medtronic Pain Management Products
6.9.2.1 RestoreSensor Neurostimulator
6.9.2.2 RestoreUltra Neurostimulator
6.9.2.3 SynchroMed II Drug Pump
6.10 Pain Management Technologies Inc
6.10.1 Pain Management Technologies Inc’s Products
6.11 St Jude Medical
6.11.1 St Jude Medical: Historical Revenue Analysis, 2009-2013
6.11.2 St Jude Medical: Pain Management Products
6.11.3 Axium Neurostimulator System – SJM and Spinal Modulation
7. Pain Management Devices: R&D Pipeline 2014-2024
7.1 Peripheral Nerve Stimulation – Pipeline Products
7.1.1 Altius System High Frequency Nerve Block (Neuros Medical)
7.1.2 MicroStim System (MicroTransponder Inc)
7.1.3 Senza SCS System (Nevro Corporation)
7.2 Analgesic Infusion Systems – Pipeline Products
7.2.1 Programmable Implantable DDS (Palyon Medical Corporation)
7.2.2 Zalviso (AcelRx Pharmaceuticals)
7.3 Occipital Nerve Stimulation – Pipeline Products
7.3.1 Precision System (Boston Scientific)
7.4 Radiofrequency Ablation – Pipeline Products
7.4.1 Intracept (Relievant Medsystems Inc)
8. Qualitative Analysis of the Pain Management Devices Market, 2014-2024
8.1 SWOT Analysis Of The Pain Management Devices Market, 2014-2024
8.1.1 Strengths
8.1.1.1 Cost Effectiveness: A Central Driver For Growth
8.1.1.2 Positive Side Effect Profile Of Pain Management Devices Compared With Pain Relieving Drugs
8.1.2 Weaknesses
8.1.2.1 Short Term Pain Relief
8.1.2.2 Mechanisms Of Action Not Fully Understood
8.1.2.3 Lack Of Evidence To Support The Efficacy And Safety Of Some Therapies
8.1.2.4 Devices Failing In Clinical Trials
8.1.2.5 Education In Pain Management Is A Key Unmet Need
8.1.3 Opportunities
8.1.3.1 Expanding Disease Indications Driving Neurostimulation for Pain Relief
8.1.3.2 The Potential Of Personalised Medicine
8.1.3.3 Expansion Into Emerging Markets
8.1.3.4 Ageing Population – Growth Driver For Pain Management
8.1.4 Threats
8.1.4.1 Increasing Regulatory And Pricing Scrutiny
8.1.4.2 Medical Device Excise Tax: A Drain On Innovation?
8.1.4.3 Inadequate Reimbursement Levels Limits Potential Of Pain Devices
8.2 Porter’s Five Force Analysis Of The Pain Management Device Market
8.2.1 Threat Of Substitutes: High
8.2.2 Power Of Suppliers: Medium
8.2.3 Rivalry Among Competitors: Medium
8.2.4 Bargaining Power Of Buyers: High
8.2.5 Threat Of New Entrants: Medium
9. Expert Opinions
9.1 Interview With Dr Deepak Kotak, Executive Vice President, BioElectronics Corporation
9.1.1 Pain Management Devices: Market Stratification And Brief History
9.1.2 On The Direct And Related Costs Of Pain And Pain Management
9.1.3 BioElectronics’ Products – FDA Approvals And The Quest For OTC Status
9.1.4 BioElectronic’s Product Distribution Partnerships And Entry Into The Advanced Wound Care Markets
9.1.5 On The Future Plans For Product Launch
9.1.6 The Issue Of Efficacy And Healthcare Economics And Their Impact On Pain Management Devices
9.1.7 On Future Technological Developments – Vagal Nerve And Trigeminal Nerve Stimulation
9.1.8 On The Future Challenges And Opportunities Facing Pain Management Devices Over The Next Decade
9.2 Interview With Penney Cowan, Chief Executive Officer, American Chronic Pain Association
9.2.1 On The Current State Of The Pain Management Devices Market
9.2.2 Socio-Political Influences On Pain Management Device And The Current Trends In The Market
9.2.3 ACPA’s Role In Patient Empowerment And Pain Management
9.2.4 ACPA’s Corporate Strategy And Future Plans
9.2.5 On The Misconceptions Surrounding Pain And Pain Management
9.2.6 On Factors That Will Affect Future Technology Developments In Pain Management
9.2.7 Interdisciplinary Pain Management As An Opportunity For Market Growth
10. Conclusion
10.1 Market Overview
10.2 Commercial Drivers For Pain Management Devices
10.3 Neuromodulation Looks Set For High Growth
10.4 Rising Demand From Musculoskeletal Pain Will Drive Market Growth
10.5 Leading Developers Of Pain Management Devices
10.6 Growth Concentrated In The Developed Markets Of North America And Europe
10.7 Future Prospects For Pain Management Devices
【レポート販売概要】
■ タイトル：世界の疼痛管理用デバイス市場予測：鎮痛剤注入ポンプ/脊髄刺激/高周波アブレーション等■ 英文：Pain Management Devices Market Forecast 2014-202
Future Prospects for Leading Companies
■ 発行日：2014年6月
■ 調査会社：visiongain
■ 商品コード：VISG409049
■ 調査対象地域：グローバル
- 世界のクロマトグラフィー用試薬市場2015The Global Reagents for Chromatography Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Reagents for Chromatography industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Reagents for Chromatography market analysis is provided for the international mark …
- 世界の大型トラック市場This latest just-auto report edition offers a global review of the heavy trucks sector, its manufacturers, top markets, technologies and market forecasts. This global market study offers: Heavy trucks market size estimates Latest technologies and trends Manufacturer production and sales volumes and forecasts Profiles of the major players including their strategies and prospects Market size forecas …
- Petroleum Company of Trinidad and Tobago Limited：石油・ガスバリューチェーン分析レポート2013Petroleum Company of Trinidad and Tobago Limited Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Petroleum Company of Trinidad and Tobago Limited" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Petroleum Company of Trinidad and Tobago Limited”. The report provides key information relating to oil and gas ass …
- 屋根材粘着剤の世界市場予測（～2026年）The global roofing adhesives market is projected to reach USD 5.78 Billion by 2021 in the midterm, at a CAGR of 6.75% from 2016 to 2021. This market is projected in the long term to be USD 8.01 Billion by 2026. This growth is driven by growing middle class population in emerging countries such as China, India, and Brazil. Increasing demand of elastic bonding adhesives from construction application …
- アルミ複合パネルの世界市場分析：製品別（PVDF、ポリエステル、ラミネート被覆、酸化膜）、用途別（建設、自動車、広告板、鉄道）、地域別、セグメント予測 -2014-2025The global aluminum composite panels market is expected to reach USD 8.26 billion by 2025, according to a new report by Grand View Research, Inc. The rapid growth of the construction and infrastructure industries, most notably in emerging regions, is expected to drive the growth of the aluminum composite panels (ACP) market over the coming years. The growth in population and urbanization have resu …
- ベネズエラの火力発電市場2016：発電能力、生産、投資動向、制度、企業Thermal Power in Venezuela, Market Outlook to 2030, Update 2016 - Capacity, Generation, Power Plants, Regulations and Company Profiles Summary "Thermal Power in Venezuela, Market Outlook to 2030, Update 2016 - Capacity, Generation, Power Plants, Regulations and Company Profiles” is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and underst …
- Non-Alcoholic Steatohepatitis：グローバル臨床試験レビューH1, 2013Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2013" provides data on the Non-Alcoholic Steatohepatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non-Alcoholic Steatohepatitis. It includes an overv …
- 世界のオレオケミカル市場2015The Global Oleochemicals Industry Report 2015 is a professional and in-depth study on the current state of the Oleochemicals industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Oleochemicals market analysis is provided for the international markets including development trends, competitive landscape a …
- エアフライヤーの世界市場：エンドユーザー別（住宅、商業）、販売経路別（ハイパーマーケット、スーパーマーケット、専門店、オンライン販売チャネル）Air fryer are healthier alternatives for traditional deep fryer. Air fryer plops veggies and meat in oil. However, air fryer uses small amount of oil as compared to deep fryers. Air fryers makes food crisp with a fraction of the calories and fat . The global air fryer market size was $894.3 million in 2018, and is projected to reach $1,425.7 million by 2026, registering a CAGR of 6.1% from 2019 to …
- 非アルコール性脂肪肝炎(NASH)：市場機会分析及び予測（～2018）OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update Summary GlobalData has released its new Opportunity Analyzer report, “OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update”. The NASH market is currently deserted and awaits its first NASH-specific therapy …
- 組織アブレーションの世界市場2017-2021About Tissue Ablation Tissue ablation is a minimally invasive (MI), image-guided treatment modality used to treat, modify, or destroy cells (that are cancerous). In this process, a specifically equipped needle (probe) is inserted near the site of the tissue under study, and is guided by computed tomography (CT). Once the probe is in place, electricity (RFA), radio waves (microwave ablation), or li …
- OJSC Rosneft Oil Company：石油・ガスの開発・生産動向及びコスト分析– Q1, 2013OJSC Rosneft Oil Company Oil & Gas Exploration and Production Operations and Cost Analysis – Q1, 2013 Summary OJSC Rosneft Oil Company Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- 物理セキュリティの世界市場2018-2022About Physical Security Physical security is the protection of software, personnel, hardware, data, and networks from events that can cause damage to an organization. It helps enterprises by safeguarding them against fire, terrorism, vandalism, and theft. It can be done by using various physical security devices such as CCTV surveillance, access control protocols, intruder alarms, Video Surveillan …
- 世界の実験室（研究室）オートメーション市場Laboratory automation is defined as the use of technology to streamline or substitute manual manipulation of equipment and processes. Laboratory automation offers technologies and engineering backing for state-of-the-art work flows in research, quality assurance, and diagnostics labs. Lab automation techniques are broadly finding applications in a majority of lab procedures - from simple capping a …
- 脂質異常症治療薬の世界市場予測および分析PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2023 Summary GlobalData estimates that the total market size for the 8MM in 2013 was $15.4bn, comprised of $11.0bn in branded drug sales (72%) and $4.4bn in generic sales (28%). GlobalData expects that the dyslipidemia drug market will grow at a CAGR of 9.4% over the ten year forecast period, resulting in a market value of $37 …
